ClinicalTrials.gg
Enrolling by invitationNCT07731269TapingUpdated Jul 28, 2026

Kinesiology Taping in Patients With Acute Low Back Pain

An interventional study of kinesiologic taping and standard physiotherapy in Acute Non-specific Low Back Pain, sponsored by Istanbul Rumeli University. Enrolling by invitation at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 50 Years. Per ClinicalTrials.gov, last updated 2026-07-28.

Sponsored by Istanbul Rumeli University · Not applicable, Interventional, and Treatment

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Randomized
Ages
18 Years to 50 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 295 studies in Low Back Pain with a site in Turkey — 63 open to participants now, 73 under way, none of them phase 3. Low Back Pain · Turkey.

Planned enrollment
181st of 212
30 · median 50
Started
2026
with 37 others
No phase
204 of 295
42 open now
Primary completion
2026-08
later than 47 of 72 live
Registered
282nd of 295
by date

Among the 295 studies in Low Back Pain with a site in Turkey, this one is the 181st largest by planned enrollment of the 212 interventional ones that give a count, is one of 38 that started in 2026, is one of 204 with no phase, reaches primary completion later than 47 of the 72 other live ones, and was the 282nd registered.

Low Back Pain

2,930 studies on the registry are indexed under Low Back Pain; 581 are open to participants now.

Browse Low Back Pain studies →

Open to participants now

63 of the 295 studies in Low Back Pain with a site in Turkey are open now. Recruiting first, the newest first:

58 more — sign in →

All 63 open studies →

A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →

Who these studies take

Of the 332 Low Back Pain studies recruiting now, 93 (28%) set no upper age limit and 209 (63%) stop at 75 or younger; 8 take children under 18; 46 take healthy volunteers.

This study: 18 Years to 50 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 295 studies in Low Back Pain with a site in Turkey, or all of them as a file.
02

Study summary

This prospective, randomized controlled trial will investigate the effectiveness of adding Kinesiology Taping (KT) to a standard physiotherapy program in individuals with acute non-specific low back pain. A total of 30 participants diagnosed with acute non-specific low back pain will be randomly allocated to either an experimental group receiving standard physiotherapy combined with lumbar Kinesiology Taping or a control group receiving standard physiotherapy alone.

Both groups will receive treatment three times per week for six weeks, totaling 18 treatment sessions. Outcome assessments will be performed at baseline and after completion of the intervention. Pain intensity will be evaluated using the Numeric Pain Rating Scale (NPRS), functional disability using the Roland-Morris Disability Questionnaire (RMDQ), flexibility using the sit-and-reach test, trunk lateral flexion, and trunk extension tests, and health-related quality of life using the Short Form-36 (SF-36).

The primary objective of this study is to determine whether the addition of Kinesiology Taping to a standard physiotherapy program provides greater improvements in pain, functional disability, flexibility, and quality of life than standard physiotherapy alone in individuals with acute non-specific low back pain. The findings are expected to contribute to the evidence regarding the clinical effectiveness of Kinesiology Taping as an adjunctive treatment for acute low back pain.

03

Conditions studied

  • Acute Non-specific Low Back Pain

Browse trials for

04

Who can participate

Ages eligible
18 Years to 50 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Individuals diagnosed with acute non-specific low back pain by a specialist physician.

18-50 years of age.

Voluntary participation in the study and provision of written .

Exclusion criteria

Exclusion Criteria:

  • Pregnancy. Diagnosis of osteoporosis. Presence of an oncological disease. Diagnosis of a neurological disorder. Renal insufficiency or other significant renal pathology. Sciatica or lumbar radiculopathy. Diagnosis of spondylolysis or spondylolisthesis. Diagnosis of ankylosing spondylitis. Specific low back pain due to infection, , vertebral fracture, or other identifiable spinal pathology.

History of chronic low back pain (pain lasting >12 weeks). Regular use of analgesic or anti-inflammatory medications. Low back pain secondary to trauma. Unexplained fever or unexplained weight loss (red flag symptoms).

Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Cancer (malignancy)

Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.

Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
30 participants (estimated)

Study arms

  • Experimental
    Experimental Group

    Standard physiotherapy + Kinesiology Taping

    Other: kinesiologic taping · Other: standard physiotherapy

  • Active comparator
    Standard Physical Therapy Protocol

    Participants will receive the standard physiotherapy program without Kinesiology Taping.

    Other: standard physiotherapy

Interventions

  • Otherkinesiologic taping

    Kinesiology Taping will be applied to the lumbar region by a certified physiotherapist in addition to the standard physiotherapy program. The taping technique will be standardized for all participants in the experimental group and will be renewed according to the treatment protocol throughout the 6-week intervention period.

  • Otherstandard physiotherapy

    The standard physiotherapy program will consist of conventional physiotherapy modalities and therapeutic exercises administered three times per week for 6 weeks (18 sessions). The program will be standardized and delivered by licensed physiotherapists.

06

What researchers measure

Primary outcomes

  1. Pain Intensity

    Pain intensity will be assessed using the Numeric Pain Rating Scale (NPRS). Scores range from 0 (no pain) to 10 (worst imaginable pain). Higher scores indicate greater pain intensity.

    Time frame: Baseline and Week 6 (end of treatment)

Secondary outcomes

  1. Functional Disability

    Functional disability will be assessed using the Roland-Morris Disability Questionnaire (RMDQ). Higher scores indicate greater disability.

    Time frame: Baseline and Week 6

  2. Flexibility - Sit-and-Reach Test

    Hamstring and lower back flexibility will be evaluated using the sit-and-reach test. Greater distances indicate better flexibility.

    Time frame: Baseline and Week 6

  3. Trunk Lateral Flexion

    Trunk lateral flexion will be measured to evaluate spinal mobility and flexibility.

    Time frame: Baseline and Week 6

  4. Trunk Extension

    Trunk extension will be measured to assess lumbar mobility.

    Time frame: Baseline and Week 6

  5. Health-Related Quality of Life

    Health-related quality of life will be evaluated using the Short Form-36 Health Survey (SF-36). Higher scores indicate better health-related quality of life.

    Time frame: Baseline and week 6

07

Study locations

1 site
08

References and documents

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: Undecided

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Jul 2026; primary completion for Aug 2026, 1 month later.

Of 1,234 non-industry interventional studies with no phase under Low Back Pain, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 26. This study's planned 1 month is below that.

Counting every sponsor, half of 1,290 studies reached it within 11 months; a quarter within 5 and three quarters within 27.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 23, 2026
First posted
Jul 28, 2026
StartEst.
Jul 30, 2026
Primary completionEst.
Aug 30, 2026
CompletionEst.
Sep 10, 2026
Last update
Jul 28, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 28, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07731269
Lead sponsor
Istanbul Rumeli University
Responsible party
Ozden Baskan (Assistant Professor, Istanbul Rumeli University) — Principal investigator
First posted
Jul 28, 2026
Start date
Jul 30, 2026 (estimated)
Primary completion
Aug 30, 2026 (estimated)
Completion
Sep 10, 2026 (estimated)
Last update
Jul 28, 2026

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion